News & Perspective

Nov 21, 2006

Nov 21, 2006

Study finds 2 mutations that help H5N1 infect humans

(CIDRAP News) – Researchers recently reported identifying two mutations in the H5N1 avian influenza virus that seem to improve its ability to attach to human cells, a finding that may help scientists spot H5N1 strains capable of infecting humans.

Nov 20, 2006

Nov 20, 2006

HHS awards 3 contracts for more H5N1 vaccine

(CIDRAP News) – The US government today announced the awarding of three contacts to buy enough additional H5N1 avian influenza vaccine to immunize almost 2.7 million people, at a cost of $199.45 million.

Sep 20, 2006

Sep 20, 2006

OIE launches Japan-funded project to fight avian flu

(CIDRAP News) – A new project to help improve control strategies for avian influenza has been initiated in eight Asian countries, the World Organization for Animal Health (OIE) announced yesterday.

Aug 18, 2006

Aug 18, 2006

WHO changes H5N1 strains for pandemic vaccines, raising concern over virus evolution

(CIDRAP News) – The World Health Organization (WHO) today changed the H5N1 avian influenza strains recommended for candidate vaccines for the first time since 2004, causing some experts to question how far the virus has evolved.

The WHO's new prototype strains, prepared by reverse genetics, include three new H5N1 subclades.

Jan 05, 2006

Jan 05, 2006

YEAR-END REVIEW: Avian flu emerged as high-profile issue in 2005

Jan 6, 2006 (CIDRAP News) – 2005 is likely to go down as the year when avian influenza, powered by a steady rise in human cases and the spread of poultry outbreaks all the way to Eastern Europe, emerged as a high-profile global health issue.

When 2005 dawned, only 45 human cases of H5N1 avian flu, including 32 deaths, had been counted by the World Health Organization (WHO). All of those were in Vietnam and Thailand.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»